Cargando…
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Data were from a real-world, open-label, prospective, an...
Autores principales: | Alcaraz, Antonio, Castro-Díaz, David, Gacci, Mauro, Salonia, Andrea, Ficarra, Vincenzo, Carballido-Rodríguez, Joaquín, Rodríguez-Antolín, Alfredo, Medina-Polo, José, Fernández-Gómez, Jesús M., Cózar-Olmo, José M., Búcar-Terrades, Santiago, Pérez-León, Noemí, Brenes-Bermúdez, Francisco J., Molero-García, José M., Fernández-Pro-Ledesma, Antonio, Herdman, Michael, Angulo, Javier C., Manasanch, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267652/ https://www.ncbi.nlm.nih.gov/pubmed/35806900 http://dx.doi.org/10.3390/jcm11133615 |
Ejemplares similares
-
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021) -
Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
por: Alcaraz, Antonio, et al.
Publicado: (2020) -
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022) -
The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022) -
Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED
por: Sebastianelli, A., et al.
Publicado: (2020)